{'fraction_non_alphanumeric': 0.010319917440660475, 'fraction_numerical': 0.0, 'mean_word_length': 5.466666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The role of ketorolac tromethamine in a clinical care pathway for men undergoing radical retropubic prostatectomy.

The use of ketorolac in managing postoperative pain after a variety of surgical procedures has potential advantages over the use of narcotic analgesics alone. The purpose of this study was to determine whether the addition of ketorolac influenced the time to resumption of a full diet, hospital discharge, and postoperative complication rates, compared to a group of patients receiving only narcotic analgesics whose postoperative management was otherwise similar. The group receiving ketorolac had an earlier return to full diet than those receiving narcotics alone. Similarly, the median length of hospital stay was shorter in the ketorolac group then the group treated with narcotics alone. The inclusion of ketorolac in the postoperative pain management of patients after radical retropubic prostatectomy appears to be a safe and effective strategy.